Vera Therapeutics VERA
NASDAQ VERA
$30.09 +0.06 (+0.22%)
As of: Nov 11, 2026 · 10:07 AM EST

Vera Therapeutics (VERA) Net Equity Issued and Repurchased (2020 - 2026)

Updated

Vera Therapeutics (VERA) recorded Net Equity Issued and Repurchased of $1.92 million in Q2 2026, up 313.4% from $464,000 a year earlier but down 51.3% from the prior quarter.

Analysis

Vera Therapeutics (VERA) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

On a TTM basis, Vera Therapeutics' Net Equity Issued and Repurchased came in at $310.84 million as of Jun 30, 2026, down 11.2% year-over-year; for FY2025, it was $306.98 million, down 52.5% from FY2024.

  • Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 30.8% (FY2020 to FY2025).
  • Across earlier years, Net Equity Issued and Repurchased came in at $645.9 million in FY2024 (+456.5%), $116.06 million in FY2023 (+31.6%), $88.21 million in FY2022 (+70.5%) and $51.73 million in FY2021 (-35.5%).
  • Quarterly Net Equity Issued and Repurchased has ranged from $48,000 in Q2 2022 to $347.31 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased rose in four of the last seven quarters, with growth averaging 61.6%.
  • Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 800.0% in Q2 2023, against a decline of 99.9% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3.94 million (Q1 2026), $304.19 million (Q4 2025) and $797,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vera Therapeutics 2.17 Bn -23.42 Mn 6.98 Mn 3.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.71 Mn
Jun 30, 2026 1.92 Mn
Mar 31, 2026 3.94 Mn
Dec 31, 2025 304.19 Mn
Sep 30, 2025 797,000.00
Jun 30, 2025 464,000.00
Mar 31, 2025 1.53 Mn
Dec 31, 2024 347.31 Mn
Sep 30, 2024 752,000.00
Jun 30, 2024 3.44 Mn
Mar 31, 2024 294.41 Mn
Dec 31, 2023 87,000.00
Sep 30, 2023 297,000.00
Jun 30, 2023 432,000.00
Mar 31, 2023 115.24 Mn
Dec 31, 2022 826,000.00
Sep 30, 2022 976,000.00
Jun 30, 2022 48,000.00
Mar 31, 2022 86.36 Mn
Jun 30, 2021 51.38 Mn
API Access

Vera Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VERA&period=max&api_key=YOUR_API_KEY